Skip to main content

Gage L Patrick's Form 4 filing

Cytokinetics Inc (CYTK) · filed Nov 8, 2021

Accession no.
0001061983-21-000253
Filed
Nov 8, 2021
Trade date
Nov 8, 2021
Filing delay
Same day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.09M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Gage L PatrickCIK 0001196903Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 8, 2021Common StockMOption exerciseAcquired+22,302$4.02+$89,654.0451,234Direct
Nov 8, 2021Common StockSSaleDisposed−22,302$41.33−$921,741.6628,932Direct
Nov 8, 2021Common StockMOption exerciseAcquired+4,166$5.46+$22,746.3633,098Direct
Nov 8, 2021Common StockSSaleDisposed−4,166$41.33−$172,180.7828,932Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 8, 2021Common StockMOption exerciseDisposed−22,302$0.00$00Direct
Nov 8, 2021Common StockMOption exerciseDisposed−4,166$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)